Supernus Pharmaceuticals reported $240.81M in Current Liabilities for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Adamas Pharmaceuticals ADMS:US 29.18M 5.69M
Aerie Pharmaceuticals AERI:US $ 93.36M 11.11M
Ani Pharmaceuticals ANIP:US $ 82.77M 4.2M
Antares Pharma ATRS:US $ 72.14M 8.94M
Aphria Inc APH:CN C$ 216.99M 75.99M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Canopy Growth Corp WEED:CN C$ 284.33M 63.89M
Cara Therapeutics CARA:US $ 16.52M 1.96M
Corcept Therapeutics CORT:US $ 45.4M 4.8M
Eisai 4523:JP Y 256017M 64587M
Eli Lilly And LLY:US $ 11714.2M 767.4M
Endo International Ordinary Shares ENDP:US $ 1395.49M 141.67M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Horizon Pharma HZNP:US $ 773.84M 101.9M
JAZZ PHA JAZZ:US $ 752.09M 98.35M
Lannett LCI:US $ 97.13M 66.54M
Marinus Pharmaceuticals MRNS:US $ 16.12M 5.39M
Pacira Pharmaceuticals PCRX:US $ 232.08M 21.24M
Perrigo Ordinary Shares PRGO:US $ 1446.8M 64.8M
Revance Therapeutics RVNC:US $ 50.84M 10.13M
Supernus Pharmaceuticals SUPN:US $ 240.81M 4.3M
Teva Pharmaceutical Industries TEVA:US $ 12691M 602M
United Therapeutics UTHR:US $ 302.4M 20.9M
Xeris Pharmaceuticals Inc XERS:US $ 27.42M 783K